## APH: Amphenol Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -5.5% below STRENGTH zone (3.0-6.0%); PEG 1.11 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($120.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Amphenol Corp. Cl A stock underperforms Friday when compared to competitors**
- Source: MarketWatch | 20251212T163000 | Bearish | Relevance: 97%
- Amphenol Corp. Cl A (APH) stock declined by 7.08% on Friday, closing at $129.24, despite a two-day winning streak being snapped. This underperformance occurred during a generally negative trading session where the S&P 500 Index (SPX) fell by 1.07% and the Dow Jones Industrial Average (DJIA) dropped by 0.51%.

**2. Effective Execution Lifted Amphenol Corp (AMP) in Q3**
- Source: Insider Monkey | 20251215T081200 | Somewhat-Bullish | Relevance: 91%
- TimesSquare Capital Management's "U.S. Focus Growth Strategy" Q3 2025 investor letter highlighted Amphenol Corporation (NYSE: APH) for its strong performance driven by effective execution. Despite macroeconomic challenges, Amphenol's Q3 sales were up 53% in US dollars, and its stock gained 71.52% over the last 52 weeks. The company's growth was also boosted by rising data center spending expectations due to accelerating AI adoption.

**3. Coherent, Plexus, TTM Technologies, Cogent, and Amphenol Shares Are Falling, What You Need To Know**
- Source: Markets Financial Content | 20251212T165500 | Somewhat-Bearish | Relevance: 90%
- Shares of Coherent (COHR), Plexus (PLXS), TTM Technologies (TTMI), Cogent (CCOI), and Amphenol (APH) fell in the afternoon session. This decline is attributed to investors rotating out of AI-linked high-flyers after underwhelming earnings from Oracle and Broadcom, shifting the focus from growth to proven returns. Coherent saw a 9.3% drop, further impacted by Bain Capital's continued sale of its shares.

**4. Daktronics' Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall**
- Source: Yahoo Finance | 20251212T153100 | Somewhat-Bullish | Relevance: 84%
- Daktronics reported strong Q2 fiscal 2026 results, with earnings and revenues surpassing estimates and significant year-over-year growth in both areas. Despite this positive financial performance, the company's shares experienced a decline, underperforming the broader Zacks Computer & Technology sector. The company highlighted growth in Live Events and International revenues, along with substantial order backlog, and provided optimistic guidance for Q3 and fiscal 2028 targets.

**5. Top Analyst Reports for Visa, Charles Schwab & Amphenol**
- Source: TradingView | 20251212T210814 | Somewhat-Bullish | Relevance: 83%
- This article presents top analyst reports from Zacks Equity Research on prominent stocks like Visa (V), Charles Schwab (SCHW), and Amphenol (APH), highlighting their current performance, future prospects, and key concerns. It also includes reports on micro-cap companies Autoscope Technologies (AATC) and United-Guardian (UG), detailing their market positions and growth drivers. Additionally, it features brief analyses of other companies like American Express (AXP), BHP Group (BHP), and Trane Technologies (TT), focusing on their strengths and challenges.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Barclays | $143 | $120 | +19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Barclays | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 7 ($17.10M) |
| Sells | 8 ($29.86M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (-10.9%)
- Blackrock Inc.: 8.2% (+6.7%)
- FMR, LLC: 8.1% (-8.1%)
- State Street Corpora: 4.6% (+1.2%)
- Price (T.Rowe) Assoc: 3.6% (+5.8%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-5.0% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $30M sold (8 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.11 suggests fair value with growth premium. Quality metrics strong (ROE 35%, ROA 14%, margin 18%). Balance sheet: strong liquidity (2.1x), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +19%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $158.2B |
| Beta | 1.19 |
| 52W Range | $56.45 - $144.37 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.11 |
| Forward P/E | 32.3 |
| Current P/E | 39.1 |
| YoY Growth | 21.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from -0.4% to -5.5% (-5.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.5pp (needs >3.0% for momentum thesis). Underperforming sector by 5.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.26x) but short-term weakness (below SMA20). MACD histogram bearish (-0.88), momentum weakening. OFD pattern: -FTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.46% (CS: 3) | Weak |
| RSI_14 | 37.8 | Neutral |
| MACD Histogram | -0.88 | Bearish |
| vs SMA20 | 0.945x | Below |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 1.262x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $129.24
- **Stop Loss:** $120.16 (7.0% risk)
- **Target:** $138.32 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 110
- **Position Value:** $14,216.40
- **Portfolio %:** 14.22%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-28 (Est: $0.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.80 | $0.93 | +16.5% |
| 2025Q2 | $0.67 | $0.81 | +21.7% |
| 2025Q1 | $0.52 | $0.63 | +21.0% |
| 2024Q4 | $0.50 | $0.55 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*